Jefferies Group’s Abiomed Inc ABMD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Hold |
0
| – | – | – | 1456 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 1345 |
|
2021
Q3 | – | Sell |
-5,010
| Closed | -$1.56M | – | 1402 |
|
2021
Q2 | $1.56M | Buy |
+5,010
| New | +$1.56M | 0.01% | 494 |
|
2021
Q1 | – | Sell |
-26,820
| Closed | -$8.7M | – | 1391 |
|
2020
Q4 | $8.7M | Buy |
26,820
+18,920
| +239% | +$6.13M | 0.07% | 122 |
|
2020
Q3 | $2.19M | Buy |
+7,900
| New | +$2.19M | 0.02% | 288 |
|
2020
Q2 | – | Sell |
-4,985
| Closed | -$743K | – | 1264 |
|
2020
Q1 | $743K | Sell |
4,985
-3,572
| -42% | -$532K | 0.01% | 540 |
|
2019
Q4 | $1.46M | Buy |
8,557
+5,746
| +204% | +$980K | 0.01% | 644 |
|
2019
Q3 | $500K | Buy |
+2,811
| New | +$500K | ﹤0.01% | 1062 |
|
2019
Q2 | – | Sell |
-1,000
| Closed | -$286K | – | 1903 |
|
2019
Q1 | $286K | Buy |
+1,000
| New | +$286K | ﹤0.01% | 1122 |
|
2018
Q4 | – | Sell |
-22,657
| Closed | -$10.2M | – | 1815 |
|
2018
Q3 | $10.2M | Sell |
22,657
-13,485
| -37% | -$6.06M | 0.07% | 78 |
|
2018
Q2 | $14.8M | Buy |
36,142
+25,115
| +228% | +$10.3M | 0.08% | 55 |
|
2018
Q1 | $3.21M | Buy |
+11,027
| New | +$3.21M | 0.02% | 306 |
|
2017
Q3 | – | Sell |
-2,812
| Closed | -$403K | – | 1818 |
|
2017
Q2 | $403K | Buy |
+2,812
| New | +$403K | ﹤0.01% | 1061 |
|
2016
Q4 | – | Sell |
-6,464
| Closed | -$831K | – | 1549 |
|
2016
Q3 | $831K | Buy |
6,464
+1,564
| +32% | +$201K | ﹤0.01% | 640 |
|
2016
Q2 | $536K | Buy |
+4,900
| New | +$536K | ﹤0.01% | 673 |
|
2015
Q3 | – | Sell |
-3,262
| Closed | -$214K | – | 2163 |
|
2015
Q2 | $214K | Buy |
3,262
+2,749
| +536% | +$180K | ﹤0.01% | 1109 |
|
2015
Q1 | $37K | Buy |
+513
| New | +$37K | ﹤0.01% | 1230 |
|